We will rely on you to help lend your voice and support the biotechnology industry.
Learn more about BIO initiatives to advance the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO CEO & Investor Conference
February 12-13, 2018
BIO IP Counsels Committee Conference
April 11-13, 2018
BIO Industry Analysis Reports
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
July 16 - 19, 2018 | Philadelphia, Pennsylvania
Based in Emerald’s Toronto office, Neil Cameron’s sector expertise is in the field of advanced materials and processes. As an Investment Director, he is involved in all phases of the investment process: sourcing, evaluating, selecting and supporting novel sustainable technology start-ups from early diligence to exit. Neil has various Board and committee responsibilities in the portfolio. He is a Director of Emerald Technology Ventures Inc. and is a member of the Investment Committee for the Emerald Canadian Cleantech Fund.
Prior to joining Emerald in 2006, Neil was a project leader and staff scientist with the National Research Council of Canada (Industrial Materials Institute), was a Research Associate at McGill University and has consulted on technical and IP issues. Projects have included work in nanotechnology, high-fidelity micro- & nanofabrication, polymer synthesis & applications, industrial biotechnology, petrochemistry, interfacial interactions and he is the co-inventor of a patented water-purification resin.
Neil has a PhD in Chemistry from McGill University, a BSc in Chemistry and Biochemistry from the University of King’s College (Dalhousie University) and is fluent in English and French.
This speaker's sessions: